Related Experiment Video
Updated: Jun 7, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Rationale for triple-combination therapy for management of high blood pressure
1Division of Cardiovascular Diseases, The Western Pennsylvania Hospital, Philadelphia, PA 15224, USA. gradmanmd@aol.com
Insights
Early combination therapy, especially triple-drug regimens, offers superior blood pressure control and adherence compared to monotherapy for hypertension management. Single-pill options further enhance patient compliance.
Area of Science:
- Cardiology
- Pharmacology
- Internal Medicine
Background:
- Antihypertensive therapy aims for optimal blood pressure reduction and long-term adherence.
- Monotherapy often fails to achieve treatment goals in most hypertension patients.
- Early combination therapy provides faster blood pressure control than stepped-care approaches.
Purpose of the Study:
- To review the rationale for combination antihypertensive therapy, focusing on triple-drug regimens.
- To identify optimal combinations for improved blood pressure control and reduced side effects.
- To discuss the role of fixed-dose combination therapy in enhancing patient adherence.
Main Methods:
- Review of existing literature and clinical trial data on antihypertensive combination therapy.
- Analysis of evidence supporting triple-combination therapy efficacy and safety.
- Discussion of single-pill (fixed-dose) combination strategies.
Main Results:
- Combination therapy, particularly early triple-drug regimens, leads to more rapid and effective blood pressure control.
- Specific combinations show promise for better efficacy, tolerability, and reduced target organ damage.
- Fixed-dose combination pills improve patient adherence to antihypertensive treatment.
Conclusions:
- Early initiation of triple-drug antihypertensive therapy is a viable strategy for achieving optimal blood pressure control.
- Careful selection of drug combinations is crucial for maximizing benefits and minimizing adverse effects.
- Single-pill combination therapy is a key tool for improving long-term adherence and clinical outcomes in hypertension management.
Abstract:
The goals of antihypertensive therapy include optimal reduction in blood pressure (BP) while providing a favorable tolerability profile that promotes long-term adherence to treatment. For most patients with hypertension, these treatment goals cannot be achieved with monotherapy. When instituted early, however, combination therapy results in more rapid control of BP. This approach may facilitate improvements in long-term clinical outcomes, compared with more traditional and time-consuming stepped care and add-on algorithms for the management of hypertension. This review summarizes the rationale behind combination therapy, specifically triple-combination therapy, and discusses which combinations are most likely to result in better BP control, fewer side effects, and reduced risk of target organ damage. Supporting evidence from recent triple-combination therapy trials also is included in the review. Finally, the role of single-pill (fixed-dose) combination therapy in enhancing patient adherence is also discussed.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Atherosclerosis III: Management
Hypertension and Regulation of Blood Pressure
Hypertension V: Nursing Management
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Combined Effects of Drugs: Synergism
Such synergistic combinations...